We are analyzing https://link.springer.com/article/10.1007/s11523-016-0452-7.

Title:
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma | Targeted Oncology
Description:
Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced stages. Chemotherapeutic agents such as doxorubicin are currently used as first-line agents for HCC therapy, but these are non-selective cytotoxic molecules with significant side effects. Sorafenib, a multi-targeted tyrosine kinase inhibitor, is the only approved targeted drug for HCC patients. However, due to adverse side effects and limited efficacy, there is a need for the identification of novel pharmacological drugs beyond sorafenib. Several agents that target and inhibit various signaling pathways involved in HCC are currently being assessed for HCC treatment. In the present review article, we summarize the diverse signal transduction pathways responsible for initiation as well as progression of HCC and also the potential anticancer effects of selected targeted therapies that can be employed for HCC therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

pubmed, article, google, scholar, cas, hepatocellular, carcinoma, cancer, hepatitis, central, sorafenib, signaling, virus, growth, human, cell, protein, oncol, hcc, advanced, patients, hepatology, pathway, treatment, liver, resistance, research, targeted, therapy, clin, pathways, stat, activation, phase, swamy, kinase, cells, university, targeting, shanmugam, sethi, chronic, therapies, molecular, therapeutic, gastroenterol, mol, role, hepatol, res,

Topics {✒️}

nanjunda swamy shivananju month download article/chapter growth factor signaling ras/raf/mek/erk pathway mitogen-activated protein kinase pi3k/akt/mtor pathway molecular targeted therapies pi3k/akt/mtor pathways hepatitis c-related cirrhosis kinase-targeted therapies protein upregulates beta-catenin targeted cancer therapies selected targeted therapies molecular viral oncology proapoptotic receptor agonists lupeol inhibits growth stat3/jak2 signaling cascade trans-ancestry mutational landscape n-nitrosodiethylamine induced hepatocarcinogenesis blocking ras/raf/mapk igf receptor signalling wnt/beta-catenin signaling full article pdf akt/mtor pathway article swamy approved targeted drug present review article celastrol suppresses growth targeted therapy biosciences research precinct targeting cell signaling hedgehog/gli1 signaling chung yeng looi privacy choices/manage cookies raf-independent pathway signaling pathways involved semin liver dis dig liver dis lee jh phase ii study stat3 signaling pathway jak/stat pathway transcription-3 signalling cascade phase iii randomised hepatocellular carcinomas identifies check access nf-kappa martinez-moreno jm microrna-155 promotes hepatocarcinogenesis instant access

Questions {❓}

Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
         description:Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced stages. Chemotherapeutic agents such as doxorubicin are currently used as first-line agents for HCC therapy, but these are non-selective cytotoxic molecules with significant side effects. Sorafenib, a multi-targeted tyrosine kinase inhibitor, is the only approved targeted drug for HCC patients. However, due to adverse side effects and limited efficacy, there is a need for the identification of novel pharmacological drugs beyond sorafenib. Several agents that target and inhibit various signaling pathways involved in HCC are currently being assessed for HCC treatment. In the present review article, we summarize the diverse signal transduction pathways responsible for initiation as well as progression of HCC and also the potential anticancer effects of selected targeted therapies that can be employed for HCC therapy.
         datePublished:2016-08-11T00:00:00Z
         dateModified:2016-08-11T00:00:00Z
         pageStart:1
         pageEnd:10
         sameAs:https://doi.org/10.1007/s11523-016-0452-7
         keywords:
            Sorafenib
            Hepatocyte Growth Factor
            Everolimus
            Platelet Derive Growth Factor Receptor
            Perifosine
            Oncology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0452-7/MediaObjects/11523_2016_452_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0452-7/MediaObjects/11523_2016_452_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0452-7/MediaObjects/11523_2016_452_Fig3_HTML.gif
         isPartOf:
            name:Targeted Oncology
            issn:
               1776-260X
               1776-2596
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Supritha G. Swamy
               affiliation:
                     name:JSS Science and Technology University
                     address:
                        name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vivek H. Kameshwar
               affiliation:
                     name:JSS Science and Technology University
                     address:
                        name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Priya B. Shubha
               affiliation:
                     name:University of Mysore
                     address:
                        name:Department of Studies in Chemistry, University of Mysore, Mysore, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chung Yeng Looi
               affiliation:
                     name:University of Malaya
                     address:
                        name:Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Muthu K. Shanmugam
               affiliation:
                     name:National University of Singapore
                     address:
                        name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frank Arfuso
               affiliation:
                     name:Curtin University
                     address:
                        name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arunasalam Dharmarajan
               affiliation:
                     name:Curtin University
                     address:
                        name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gautam Sethi
               affiliation:
                     name:National University of Singapore
                     address:
                        name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
                        type:PostalAddress
                     type:Organization
                     name:Curtin University
                     address:
                        name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nanjunda Swamy Shivananju
               affiliation:
                     name:JSS Science and Technology University
                     address:
                        name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Anupam Bishayee
               affiliation:
                     name:Larkin Health Sciences Institute
                     address:
                        name:Department of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
      description:Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced stages. Chemotherapeutic agents such as doxorubicin are currently used as first-line agents for HCC therapy, but these are non-selective cytotoxic molecules with significant side effects. Sorafenib, a multi-targeted tyrosine kinase inhibitor, is the only approved targeted drug for HCC patients. However, due to adverse side effects and limited efficacy, there is a need for the identification of novel pharmacological drugs beyond sorafenib. Several agents that target and inhibit various signaling pathways involved in HCC are currently being assessed for HCC treatment. In the present review article, we summarize the diverse signal transduction pathways responsible for initiation as well as progression of HCC and also the potential anticancer effects of selected targeted therapies that can be employed for HCC therapy.
      datePublished:2016-08-11T00:00:00Z
      dateModified:2016-08-11T00:00:00Z
      pageStart:1
      pageEnd:10
      sameAs:https://doi.org/10.1007/s11523-016-0452-7
      keywords:
         Sorafenib
         Hepatocyte Growth Factor
         Everolimus
         Platelet Derive Growth Factor Receptor
         Perifosine
         Oncology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0452-7/MediaObjects/11523_2016_452_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0452-7/MediaObjects/11523_2016_452_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0452-7/MediaObjects/11523_2016_452_Fig3_HTML.gif
      isPartOf:
         name:Targeted Oncology
         issn:
            1776-260X
            1776-2596
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Supritha G. Swamy
            affiliation:
                  name:JSS Science and Technology University
                  address:
                     name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vivek H. Kameshwar
            affiliation:
                  name:JSS Science and Technology University
                  address:
                     name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Priya B. Shubha
            affiliation:
                  name:University of Mysore
                  address:
                     name:Department of Studies in Chemistry, University of Mysore, Mysore, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chung Yeng Looi
            affiliation:
                  name:University of Malaya
                  address:
                     name:Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Muthu K. Shanmugam
            affiliation:
                  name:National University of Singapore
                  address:
                     name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frank Arfuso
            affiliation:
                  name:Curtin University
                  address:
                     name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arunasalam Dharmarajan
            affiliation:
                  name:Curtin University
                  address:
                     name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gautam Sethi
            affiliation:
                  name:National University of Singapore
                  address:
                     name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
                     type:PostalAddress
                  type:Organization
                  name:Curtin University
                  address:
                     name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nanjunda Swamy Shivananju
            affiliation:
                  name:JSS Science and Technology University
                  address:
                     name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Anupam Bishayee
            affiliation:
                  name:Larkin Health Sciences Institute
                  address:
                     name:Department of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Targeted Oncology
      issn:
         1776-260X
         1776-2596
      volumeNumber:12
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:JSS Science and Technology University
      address:
         name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
         type:PostalAddress
      name:JSS Science and Technology University
      address:
         name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
         type:PostalAddress
      name:University of Mysore
      address:
         name:Department of Studies in Chemistry, University of Mysore, Mysore, India
         type:PostalAddress
      name:University of Malaya
      address:
         name:Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
         type:PostalAddress
      name:National University of Singapore
      address:
         name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
         type:PostalAddress
      name:Curtin University
      address:
         name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
         type:PostalAddress
      name:Curtin University
      address:
         name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
         type:PostalAddress
      name:National University of Singapore
      address:
         name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
         type:PostalAddress
      name:Curtin University
      address:
         name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
         type:PostalAddress
      name:JSS Science and Technology University
      address:
         name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
         type:PostalAddress
      name:Larkin Health Sciences Institute
      address:
         name:Department of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Supritha G. Swamy
      affiliation:
            name:JSS Science and Technology University
            address:
               name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
               type:PostalAddress
            type:Organization
      name:Vivek H. Kameshwar
      affiliation:
            name:JSS Science and Technology University
            address:
               name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
               type:PostalAddress
            type:Organization
      name:Priya B. Shubha
      affiliation:
            name:University of Mysore
            address:
               name:Department of Studies in Chemistry, University of Mysore, Mysore, India
               type:PostalAddress
            type:Organization
      name:Chung Yeng Looi
      affiliation:
            name:University of Malaya
            address:
               name:Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
               type:PostalAddress
            type:Organization
      name:Muthu K. Shanmugam
      affiliation:
            name:National University of Singapore
            address:
               name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
               type:PostalAddress
            type:Organization
      name:Frank Arfuso
      affiliation:
            name:Curtin University
            address:
               name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
               type:PostalAddress
            type:Organization
      name:Arunasalam Dharmarajan
      affiliation:
            name:Curtin University
            address:
               name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
               type:PostalAddress
            type:Organization
      name:Gautam Sethi
      affiliation:
            name:National University of Singapore
            address:
               name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
               type:PostalAddress
            type:Organization
            name:Curtin University
            address:
               name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
               type:PostalAddress
            type:Organization
      name:Nanjunda Swamy Shivananju
      affiliation:
            name:JSS Science and Technology University
            address:
               name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Anupam Bishayee
      affiliation:
            name:Larkin Health Sciences Institute
            address:
               name:Department of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
      name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
      name:Department of Studies in Chemistry, University of Mysore, Mysore, India
      name:Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
      name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
      name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
      name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
      name:Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
      name:School of Biomedical Sciences, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, Bentley, Australia
      name:Department of Biotechnology, JSS Science and Technology University, Mysore, India
      name:Department of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(370)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.4s.

LINK . SPRINGER . COM {}